Growth Metrics

Zymeworks (ZYME) Cash from Financing Activities (2021 - 2025)

Zymeworks' Cash from Financing Activities history spans 5 years, with the latest figure at -$18.7 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 116.87% to -$18.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$18.6 million, a 9.19% increase, with the full-year FY2025 number at -$18.6 million, up 9.19% from a year prior.
  • Cash from Financing Activities hit -$18.7 million in Q4 2025 for Zymeworks, down from -$2.5 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ZYME hit a ceiling of $108.6 million in Q1 2022 and a floor of -$18.7 million in Q4 2025.
  • Historically, Cash from Financing Activities has averaged $8.9 million across 5 years, with a median of $1.1 million in 2024.
  • Biggest five-year swings in Cash from Financing Activities: soared 13530.24% in 2023 and later tumbled 889.87% in 2024.
  • Tracing ZYME's Cash from Financing Activities over 5 years: stood at $689000.0 in 2021, then crashed by 154.72% to -$377000.0 in 2022, then soared by 13530.24% to $50.6 million in 2023, then plummeted by 117.07% to -$8.6 million in 2024, then plummeted by 116.87% to -$18.7 million in 2025.
  • Business Quant data shows Cash from Financing Activities for ZYME at -$18.7 million in Q4 2025, -$2.5 million in Q3 2025, and $1.3 million in Q2 2025.